The Chronic Pain Solution
Nevro (nevro.com) scores 76 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 48th percentile of 13177 Healthcare brands.
Nevro is a medical technology company that develops spinal cord stimulation therapy for chronic pain management. Its primary offering, HFX 10 kHz Therapy, is an FDA-approved system designed to provide individualized relief for conditions such as chronic back pain and painful diabetic neuropathy. The company targets physicians, pain management specialists, and patients suffering from chronic pain, positioning its platform as a clinically validated alternative to traditional pain treatments.
| Brand Name | Nevro |
|---|---|
| Domain | nevro.com |
| Industry | Healthcare, Technology |
| Main Competitors | Medtronic (83/100), Boston Scientific (80/100), Abbott (91/100), Saluda Medical (77/100) |
Moz Domain Authority 44/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,014,395 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To provide innovative, individualized spinal cord stimulation therapy that delivers lasting relief for people suffering from chronic pain." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Nevro?", Claude could identify the brand as of October 2026. Nevro is a medical device company known for its HFX spinal cord stimulation (SCS) system used to treat chronic pain, including back and leg pain. Its signature technology delivers high-frequency stimulation at 10 kHz, distinguishing it from older, lower-frequency SCS systems. Best known for HFX spinal cord stimulator using high-frequency (10 kHz) therapy for chronic pain management.
When asked "Best brands similar to Nevro?", Claude would recommend Nevro as of October 2026. Nevro is a well-known, publicly traded leader in spinal cord stimulation for chronic pain and would naturally come up alongside competitors like Medtronic, Boston Scientific, and Abbott in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Nevro's main competitors in Healthcare: Medtronic (83/100), Boston Scientific (80/100), Abbott (91/100), Saluda Medical (77/100).
Sources: Brand Analyzer scan
Nevro has limited AI-search visibility, scoring 29/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 37, recommendation 42). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Nevro official site
Nevro offers the HFX 10 kHz Therapy system, an FDA-approved spinal cord stimulation device for chronic pain management. It provides individualized therapy with specific indications for painful diabetic neuropathy and non-surgical back pain.
Sources: Nevro official site
Nevro scores 42/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Nevro official site
Nevro is a medical technology company that develops spinal cord stimulation (SCS) systems for the treatment of chronic pain. Its flagship product, HFX 10 kHz Therapy, is an FDA-approved device designed to deliver individualized pain relief to patients suffering from conditions like chronic back pain and diabetic neuropathy.
Sources: Nevro official site
Nevro designs and provides spinal cord stimulation therapy systems used to treat chronic pain. Its core technology, HFX 10 kHz Therapy, delivers electrical stimulation to the spinal cord to help manage pain, including specific FDA-approved indications for painful diabetic neuropathy and non-surgical back pain.
Sources: Nevro official site
Nevro can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Nevro official site
Nevro's therapy is used by patients suffering from chronic pain conditions, particularly back pain and painful diabetic neuropathy. Physicians and pain management specialists are the primary professional users who prescribe and implant the devices.
Sources: Nevro official site
Nevro is known for its proprietary HFX 10 kHz Therapy, a spinal cord stimulation platform marketed as a clinically validated, individualized treatment for chronic pain, including back pain and painful diabetic neuropathy.
Sources: Nevro official site
Nevro scores 29/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Nevro has a weak AI-visibility profile at 29/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (42/100) and its weakest is visibility (17/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,014,395 (Tranco) and a Moz Domain Authority of 44/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Nevro from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Nevro: Neurogene (76/100), netDoktor (76/100), NewSpring (76/100), BNF (British National Formulary) via NICE (76/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.